Protease-activated receptor 2 (PAR2)-activated TNBC cells produce EVs that induce EMT in recipient cancer cells through the AKT/nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) pathway, and contain high levels of miR-221 [77]. Here, F2RL1 is linked to cancer.